Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization

被引：3

作者：

Nilsson, Magnus ^{[1
]}

Berggren, Kristina ^{[1
]}

Berglund, Susanne ^{[1
]}

Cerboni, Silvia ^{[2
]}

Collins, Mia ^{[2
]}

Dahl, Goran ^{[3
]}

Elmqvist, David ^{[4
]}

Grimster, Neil P. ^{[5
]}

Hendrickx, Ramon ^{[6
]}

Johansson, Johan R. ^{[1
]}

Kettle, Jason G. ^{[5
]}

Lepisto, Matti ^{[1
]}

Rhedin, Magdalena ^{[2
]}

Smailagic, Amir ^{[2
]}

Su, Qibin ^{[5
]}

Wennberg, Tiiu ^{[2
]}

Wu, Allan ^{[7
]}

Osterlund, Torben ^{[8
]}

Naessens, Thomas ^{[2
]}

Mitra, Suman ^{[2
]}

机构：

[1] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Med Chem Res & Early Dev, SE-43183 Gothenburg, Sweden

[2] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Biosci Res & Early Dev, SE-43183 Gothenburg, Sweden

[3] AstraZeneca, BioPharmaceut R&D, Struct & Biophys Res & Early Dev, Discovery Sci, SE-43183 Gothenburg, Sweden

[4] AstraZeneca, BioPharmaceut R&D, Pharmaceut Sci, Early Prod Dev, SE-43183 Gothenburg, Sweden

[5] AstraZeneca R&D, Oncol R&D, Waltham, MA 02451 USA

[6] AstraZeneca, BioPharmaceut R&D, Res & Early Dev, Resp & Immunol,DMPK, SE-43183 Gothenburg, Sweden

[7] AstraZeneca R&D, Discovery Sci, R&D, Waltham, MA 02451 USA

[8] AstraZeneca, BioPharmaceut R&D, Res & Early Dev, Discovery Sci,Mechanist Biol & Profiling, SE-43183 Gothenburg, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2023年

关键词：

T-CELLS; TISSUE DISTRIBUTION; JAK1; INHIBITORS; IMMUNITY; IDENTIFICATION; MECHANISMS;

D O I：

10.1021/acs.jmedchem.3c00554

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

JAK-STAT cytokines are critical in regulating immunity. Persistent activation of JAK-STAT signaling pathways by cytokines drives chronic inflammatory diseases such as asthma. Herein, we report on the discovery of a highly JAK1-selective, ATP-competitive series of inhibitors having a 1000-fold selectivity over other JAK family members and the approach used to identify compounds suitable for inhaled administration. Ultimately, compound 16 was selected as the clinical candidate, and upon dry powder inhalation, we could demonstrate a high local concentration in the lung as well as low plasma concentrations, suggesting no systemic JAK1 target engagement. Compound 16 has progressed into clinical trials. Using 16, we found JAK1 inhibition to be more efficacious than JAK3 inhibition in IL-4-driven Th2 asthma.

引用

页码：13400 / 13415

页数：16

共 50 条

[21] Preclinical characterization of HMPL-295, a potent and selective ERK 1/2 inhibitor
Hu, Jia
Ni, Jun
Lv, Yuanzhi
Li, Wenjun
Zhang, Hui
Li, Xin
Yu, Ying
Zhong, Zeyu
Wang, Jian
Sai, Yang
Qing, Weiguo
Ren, Yongxin
Shi, Michael
Su, Weiguo
CANCER RESEARCH, 2024, 84 (06)
[22] Discovery of AZD3147: A Potent, Selective Dual Inhibitor of mTORC1 and mTORC2
Pike, Kurt G.
Morris, Jeff
Ruston, Linette
Pass, Sarah L.
Greenwood, Ryan
Williams, Emma J.
Demeritt, Julie
Culshaw, Janet D.
Gill, Kristy
Pass, Martin
Finlay, M. Raymond V.
Good, Catherine J.
Roberts, Craig A.
Currie, Gordon S.
Blades, Kevin
Eden, Jonathan M.
Pearson, Stuart E.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (05) : 2326 - 2349
[23] AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia
Keeton, Erika K.
McEachern, Kristen
Dillman, Keith S.
Palakurthi, Sangeetha
Cao, Yichen
Grondine, Michael R.
Kaur, Surinder
Wang, Suping
Chen, Yuching
Wu, Allan
Shen, Minhui
Gibbons, Francis D.
Lamb, Michelle L.
Zheng, Xiaolan
Stone, Richard M.
DeAngelo, Daniel J.
Platanias, Leonidas C.
Dakin, Les A.
Chen, Huawei
Lyne, Paul D.
Huszar, Dennis
BLOOD, 2014, 123 (06) : 905 - 913
[24] Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation
Walsh, Shawn P.
Shahripour, Aurash
Tang, Haifeng
Teumelsan, Nardos
Frie, Jessica
Zhu, Yuping
Priest, Birgit T.
Swensen, Andrew M.
Liu, Jessica
Margulis, Michael
Visconti, Richard
Weinglass, Adam
Felix, John P.
Brochu, Richard M.
Bailey, Timothy
Thomas-Fowlkes, Brande
Alonso-Galicia, Magdalena
Zhou, Xiaoyan
Pai, Lee-Yuh
Corona, Aaron
Hampton, Caryn
Hernandez, Melba
Bentley, Ross
Chen, Jing
Shah, Kashmira
Metzger, Joseph
Forrest, Michael
Owens, Karen
Tong, Vincent
Ha, Sookhee
Roy, Sophie
Kaczorowski, Gregory J.
Yang, Lihu
Parmee, Emma
Garcia, Maria L.
Sullivan, Kathleen
Pasternak, Alexander
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07): : 747 - 752
[25] Ruxolitinib: a potent and selective Janus kinase 1 and 2 inhibitor in patients with myelofibrosis. An update for clinicians
Harrison, Claire
Vannucchi, Alessandro M.
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (06) : 341 - 354
[26] Discovery and preclinical characterization of BMS-777607: a potent, small molecule inhibitor of Met receptor tyrosine kinase
Borzilleri, R.
Fargnoli, J.
EJC SUPPLEMENTS, 2008, 6 (12): : 176 - 176
[27] Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor
Yeh, Tammie C.
Marsh, Vivienne
Bernat, Bryan A.
Ballard, Josh
Colwell, Heidi
Evans, Ron J.
Parry, Janet
Smith, Darin
Brandhuber, Barbara J.
Gross, Stefan
Marlow, Allison
Hurley, Brian
Lyssikatos, Joe
Lee, Patrice A.
Winkler, James D.
Koch, Kevin
Wallace, Eli
CLINICAL CANCER RESEARCH, 2007, 13 (05) : 1576 - 1583
[28] Discovery of a Pyrimidothiazolodiazepinone as a Potent and Selective Focal Adhesion Kinase (FAK) Inhibitor
Groendyke, Brian J.
Nabet, Behnam
Mohardt, Mikaela L.
Zhang, Haisheng
Peng, Ke
Koide, Eriko
Coffey, Calvin R.
Che, Jianwei
Scott, David A.
Bass, Adam J.
Gray, Nathanael S.
ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (01): : 30 - 38
[29] Discovery of a potent, selective, and covalent ZAP-70 kinase inhibitor
Rao, Danni
Li, Heng
Ren, Xuelian
Sun, Yaoliang
Wen, Cuiyun
Zheng, Mingyue
Huang, He
Tang, Wei
Xu, Shilin
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 219
[30] Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor
Sun, Yaoliang
Chen, Zhiwen
Liu, Guobin
Chen, Xiaoai
Shi, Zihan
Feng, Huixu
Yu, Lei
Li, Guodong
Ding, Ke
Huang, He
Zhang, Zhang
Xu, Shilin
BIOORGANIC CHEMISTRY, 2024, 143

← 1 2 3 4 5 →